2021 GLOBAL FINALIST

Xiretsa

Digital Health

Xiretsa is developing a new class of antibiotics that can treat infections that are unresponsive to current antibiotics and combat the growing antibiotic resistance problem. Xiretsa's technology represents the first new class of broad-spectrum antibiotics to be discovered in the past 50 years.

📌 HQ: Santa Barbara, California, United States

🔗 https://www.xiretsapharm.com/